Legend Biotech (LEGN) Return on Invested Capital (2020 - 2025)

Legend Biotech's Return on Invested Capital history runs 6 years deep, the most recent figure standing at 0.02% for Q3 2025.

• Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.02% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 0.02% (changed 0.0% YoY) and the FY2024 annual result came in at 0.01%, down 1.0% from the prior year.
• Return on Invested Capital was 0.02% for Q3 2025 at Legend Biotech, up from 0.02% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.01% in Q4 2024 and bottomed at 1.05% in Q3 2021.
• A 5-year average of 0.18% and a median of 0.02% in 2025 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2021 — Return on Invested Capital soared 79341 bps — and 2025, when it fell 1 bps.
• Legend Biotech's Return on Invested Capital stood at 0.07% in 2021, then surged by 42 bps to 0.04% in 2022, then soared by 60 bps to 0.02% in 2023, then grew by 30 bps to 0.01% in 2024, then sank by 46 bps to 0.02% in 2025.
• Business Quant data shows LEGN's Return on Invested Capital at 0.02% in Q3 2025, 0.02% in Q2 2025, and 0.01% in Q1 2025.